New hope to protect the gut after transplant complications
NCT ID NCT06598332
Summary
This early study tested whether adding a drug called AZA to standard steroid treatment could better control a serious complication called graft-versus-host disease (GVHD) that affects the gut after a transplant. The goal was to see if this combination was safe and could protect the gut's stem cells from long-term damage, which is a known problem even when steroids help. The trial was withdrawn before enrolling any patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT-VERSUS-HOST DISEASE (GVHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.